Literature DB >> 21645162

Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy.

Martin Jeffrey1, Gillian McGovern, Emily V Chambers, Declan King, Lorenzo González, Jean C Manson, Bernardino Ghetti, Pedro Piccardo, Rona M Barron.   

Abstract

Gerstmann-Sträussler-Scheinker (GSS) P102L disease is a familial form of a transmissible spongiform encephalopathy (TSE) that can present with or without vacuolation of neuropil. Inefficient disease transmission into 101LL transgenic mice was previously observed from GSS P102L without vacuolation. However, several aged, healthy mice had large plaques composed of abnormal prion protein (PrP(d)). Here we perform the ultrastructural characterization of such plaques and compare them with PrP(d) aggregates found in TSE caused by an infectious mechanism. PrP(d) plaques in 101LL mice varied in maturity, with some being composed of deposits without visible amyloid fibrils. PrP(d) was present on cell membranes in the vicinity of all types of plaques. In contrast to the unicentric plaques seen in infectious murine scrapie, the plaques seen in the current model were multicentric and were initiated by protofibrillar forms of PrP(d) situated on oligodendroglia, astrocytes and neuritic cell membranes. We speculate that the initial conversion process leading to plaque formation begins with membrane-bound PrP(C) but that subsequent fibrillization does not require membrane attachment. We also observed that the membrane alterations consistently seen in murine scrapie and other infectious TSEs were not present in 101LL mice with plaques, suggesting differences in the pathogenesis of these conditions.
© 2011 The Authors and Crown copyright (AHVLA); Brain Pathology © 2011 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645162      PMCID: PMC3182302          DOI: 10.1111/j.1750-3639.2011.00508.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  40 in total

Review 1.  Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.

Authors:  Martin Jeffrey; Gillian McGovern; Silvia Sisó; Lorenzo González
Journal:  Acta Neuropathol       Date:  2010-06-08       Impact factor: 17.088

2.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

3.  Scrapie as a model for neuroaxonal dystrophy: ultrastructural studies.

Authors:  P P Liberski; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  Exp Neurol       Date:  1989-11       Impact factor: 5.330

4.  Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein.

Authors:  C I Lasmézas; J P Deslys; O Robain; A Jaegly; V Beringue; J M Peyrin; J G Fournier; J J Hauw; J Rossier; D Dormont
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

5.  A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V.

Authors:  F Tagliavini; P M Lievens; C Tranchant; J M Warter; M Mohr; G Giaccone; F Perini; G Rossi; M Salmona; P Piccardo; B Ghetti; R C Beavis; O Bugiani; B Frangione; F Prelli
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

6.  Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165.

Authors:  P Piccardo; B Ghetti; D W Dickson; H V Vinters; G Giaccone; O Bugiani; F Tagliavini; K Young; S R Dlouhy; C Seiler
Journal:  J Neuropathol Exp Neurol       Date:  1995-11       Impact factor: 3.685

7.  Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides.

Authors:  K Hashimoto; T Mannen; N Nukina
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.

Authors:  P Parchi; S G Chen; P Brown; W Zou; S Capellari; H Budka; J Hainfellner; P F Reyes; G T Golden; J J Hauw; D C Gajdusek; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

9.  Abnormal prion protein is associated with changes of plasma membranes and endocytosis in bovine spongiform encephalopathy (BSE)-affected cattle brains.

Authors:  C Ersdal; C M Goodsir; M M Simmons; G McGovern; M Jeffrey
Journal:  Neuropathol Appl Neurobiol       Date:  2008-09-18       Impact factor: 8.090

10.  Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie.

Authors:  H M Wisniewski; A W Vorbrodt; J Wegiel; J Morys; A S Lossinsky
Journal:  Am J Med Genet Suppl       Date:  1990
View more
  12 in total

1.  Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.

Authors:  Pedro Piccardo; Juraj Cervenak; Ming Bu; Lindsay Miller; David M Asher
Journal:  J Gen Virol       Date:  2014-04-25       Impact factor: 3.891

2.  Glycosylphosphatidylinositol anchoring directs the assembly of Sup35NM protein into non-fibrillar, membrane-bound aggregates.

Authors:  Karen E Marshall; Danielle K Offerdahl; Jonathan O Speare; David W Dorward; Aaron Hasenkrug; Aaron B Carmody; Gerald S Baron
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

3.  Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.

Authors:  M Jeffrey; G McGovern; N Makarava; L González; Y-S Kim; R G Rohwer; I V Baskakov
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

4.  Infectious prions and proteinopathies.

Authors:  Rona M Barron
Journal:  Prion       Date:  2017-01-02       Impact factor: 3.931

Review 5.  Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.

Authors:  Ilaria Poggiolini; Daniela Saverioni; Piero Parchi
Journal:  Int J Cell Biol       Date:  2013-12-24

6.  Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.

Authors:  Dae-Hwan Kim; Hye-Mi Lee; Chongsuk Ryou
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

7.  Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.

Authors:  Pedro Piccardo; Declan King; Glenn Telling; Jean C Manson; Rona M Barron
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 8.  Infectious particles, stress, and induced prion amyloids: a unifying perspective.

Authors:  Laura Manuelidis
Journal:  Virulence       Date:  2013-04-30       Impact factor: 5.882

Review 9.  Insights into Mechanisms of Chronic Neurodegeneration.

Authors:  Abigail B Diack; James D Alibhai; Rona Barron; Barry Bradford; Pedro Piccardo; Jean C Manson
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

10.  PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.

Authors:  Rona M Barron; Declan King; Martin Jeffrey; Gillian McGovern; Sonya Agarwal; Andrew C Gill; Pedro Piccardo
Journal:  Acta Neuropathol       Date:  2016-07-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.